A future high myope: diagnosis with axial length
In this article:
It is estimated that 10% of the world population will have high myopia by 2050.1 High myopia is associated with a higher risk of various ocular health issues such as retinal tears, retinal detachments, and myopic maculopathy.2 Whilst refractive error is correlated with this risk, the stronger predictor of ocular health issues and risk of vision impairment is with axial length - the point where risk significantly elevates is 26mm.3 In this case shared with the Myopia Profile community, CL discusses the management options for a child whose axial length is fast approaching this point.
Change in refraction
There are two pieces of clinical data which indicate myopia progression in this child. The most obvious would be refractive error. Various comments suggested a cycloplegic refraction to avoid a refractive error result falsely elevated by an overactive accommodative system. You can also read How To Achieve Accurate Refractions For Children for more information.
Axial length growth
The second part of this story is axial length. CL provided two sets of AXL readings separated by 3 months, showing a change of 0.13mm in that time.
Which matters most - axial length or refraction?
Of course both measurements matter - refraction is the visible concern of myopia and correcting vision is of utmost importance. As the commenters have done in this case, it is useful to compare axial length to refraction to check for potential errors in either measurement - for example by considering cycloplegic refraction as noted above. Using an optical biometry method of measuring axial length will ensure its utmost accuracy.
What can be done now?
Considering her young age and the fast rate of myopia progression, the commenters suggested combining a form of optical myopia control treatment with low-dose atropine. It is worth noting, though, that there is currently only evidence for combining orthokeratology with atropine for additive efficacy. The commenters also recommended to check compliance with the treatment and consider other options - read more advice on this in Why isn't the myopia control strategy working?
Take home messages
- Axial length data is an extremely useful tool to gauge myopic progression, in conjunction with refractive error. It can be more useful than refraction, though in alerting the clinician to the risk of myopia-associated pathology, guiding the urgency of proactive myopia management.
- Using axial length growth charts, to compare a result to age-normal percentile values, is the most reliable guide to understanding risk of myopia and high myopia, and to gauging if progression appears to be accelerated compared to averages.
Meet the Authors:
About Connie Gan
Connie is a clinical optometrist from Kedah, Malaysia, who provides comprehensive vision care for children and runs the myopia management service in her clinical practice.
About Kimberley Ngu
Kimberley is a clinical optometrist from Perth, Australia, with experience in patient education programs, having practiced in both Australia and Singapore.
This content is brought to you thanks to unrestricted educational grant from
- Holden BA, Fricke TR, Wilson DA, Jong M, Naidoo KS, Sankaridurg P, Wong TY, Naduvilath TJ, Resnikoff S. Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050. Ophthalmol. 2016 May 1;123(5):1036-42. (link)
- Flitcroft DI. The complex interactions of retinal, optical and environmental factors in myopia aetiology. Prog Retin Eye Res. 2012;31(6):622-60. (link)
- Tideman JW, Snabel MC, Tedja MS, van Rijn GA, Wong KT, Kuijpers RW, Vingerling JR, Hofman A, Buitendijk GH, Keunen JE, Boon CJ, Geerards AJ, Luyten GP, Verhoeven VJ, Klaver CC. Association of Axial Length With Risk of Uncorrectable Visual Impairment for Europeans With Myopia. JAMA Ophthalmol. 2016;134(12):1355-1363. (link)[Link to Myopia Profile Science Review]
- Rozema J, Dankert S, Iribarren R, Lanca C, Saw S-M. Axial Growth and Lens Power Loss at Myopia Onset in Singaporean Children. Invest Ophthalmol Vis Sci. 2019;60(8):3091-3099. (link)
- Chamberlain P, Peixoto-de-Matos SC, Logan NS, Ngo C, Jones D, Young G. A 3-year randomized clinical trial of MiSight lenses for myopia control. Optom Vis Sci. 2019;96:556-567. (link)
- Walline JJ, Walker MK, Mutti DO, et al. Effect of High Add Power, Medium Add Power, or Single-Vision Contact Lenses on Myopia Progression in Children: The BLINK Randomized Clinical Trial. JAMA. 2020;324(6):571-580. (link)
Enormous thanks to our visionary sponsors
Myopia Profile’s growth into a world leading platform has been made possible through the support of our visionary sponsors, who share our mission to improve children’s vision care worldwide. Click on their logos to learn about how these companies are innovating and developing resources with us to support you in managing your patients with myopia.